Gene, Drug, and Tissue Engineering

Gene Alterations Induced by Glutamine (Q) Encoding CAG Repeats Associated with Neurodegeneration.- Latest Trends in Nucleic Acid-Based Engineering Techniques Applied to Precision Medicine.- Nanotechnology Driven Delivery Systems in Inoculation Therapies.- Chronic Kidney Disease: Challenges in Translational Medicine.- Mass Spectroscopy as an Analytical Tool to Harness the Production of Secondary Plant Metabolites: The Way Forward for Drug Discovery.- Assessing the Challenges of Nanotechnology-Driven Targeted Therapies: Development of Magnetically Directed Vectors for Targeted Cancer Therapies and Beyond.- Advances in Regenerative Medicine and Biomaterials.- A Brief Review of Plant Cell Transfection, Gene Transcript Expression, and Genotypic Integration for Enhancing Compound Production.- A Review of Stem Cell Technology Targeting Hepatocyte Growth as an Alternative to Organ Transplantation.- Novel Nanotechnology-Driven Prototypes for AI-Enriched Implanted Prosthetics Following Organ Failure.- Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.- Design of SaCas9-HF for In Vivo Gene Therapy.- Stem Cell Technology in Organ Transplantation: A Novel Method for 3D Bioprinting Functional and Stable Liver Grafts Using Human iPS-Derived Cells.- In Vitro Assay for the Assessment of Oxygen Depletion Triggers in Human Cell Lines, Associated with Improving Responses to Cancer Therapy.- The Use of 99mTc-Labeled Stem Cells for Evaluation of Chronic Kidney Disease.- An Automated Strategy to Handle Antigenic Variability in Immunization Protocols, Part I: Nanopore Sequencing of Infectious Agent Variants.- An Automated Strategy to Handle Antigenic Variability in Immunization Protocols, Part II: In Vitro Transcribed mRNA Vector Design for Inoculation Against Infectious Agent Variants.